Mary Nwokedi-Nwaneri Pharmd

Mary Nwokedi-Nwaneri PharmD has a diverse work experience starting from 2010. Mary worked as a Summer Research Intern in Ophthalmic at Emory University School of Medicine in 2010. From 2013 to 2015, they served as a Lab Manager focusing on Cardiovascular Research at Temple University, where they managed grants, ensured compliance, and collaborated with international research labs. In 2017, Mary was a Campus Ambassador and later a Clinical Pharmacology-Oncology Intern at Genentech. In 2018, they worked as a Regulatory Affairs Extern in Advertising and Promotion Immunology/Dermatology at AbbVie and as a Clinical Pharmacology Extern at FDA. Mary also had a role as a Global Public Health Policy Extern at Howard University Global Health Initiative South Africa. From 2019 to 2020, Mary worked as a Visiting Scientist in U.S. Regulatory Policy & Strategy and Global Policy & Intelligence at Eli Lilly and Company. In 2020, they joined Merck as a Global Labeling Lead in Oncology. Currently, since 2021, Mary is serving as the Director of Health Equity in Clinical Trials, Science, and Regulatory Advocacy at PhRMA.

Mary Nwokedi-Nwaneri PharmD holds a Doctorate of Pharmacy (Pharm.D.) from Howard University and a Bachelor of Science (B.S.) in Biology from Allegheny College. Currently, they are pursuing a degree in Global Health Systems with a focus on Public Health at the University of Maryland, Baltimore (UMB). In addition to their formal education, Mary has obtained certifications in Comparative Health Systems and Global Health Equity from the University of Pennsylvania.